BRIEF published on 02/10/2025 at 20:11, 1 month 24 days ago Merck KGaA Explores Acquisition of Springworks Therapeutics Pharmaceutical Industry Stock Exchange Merck KGaA Acquisition Talks Springworks Therapeutics
BRIEF published on 02/10/2025 at 20:11, 1 month 24 days ago Merck KGaA envisage l'acquisition de Springworks Therapeutics Bourse Industrie Pharmaceutique Merck KGaA Discussions Sur L'acquisition Thérapeutique Springworks
PRESS RELEASE published on 02/10/2025 at 20:06, 1 month 24 days ago EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition Merck KGaA confirms advanced discussions with Springworks Therapeutics, Inc. on potential acquisition. No binding agreement has been reached yet Acquisition Discussions Merck KGaA Confirmation Springworks Therapeutics
BRIEF published on 07/26/2024 at 18:55, 8 months 11 days ago Merck KGaA Reports Strong Q2, Raises 2024 Guidance Healthcare Financial Forecast Q2 Results Merck KGaA Electronics
BRIEF published on 07/26/2024 at 18:55, 8 months 11 days ago Merck KGaA annonce un deuxième trimestre solide et relève ses prévisions pour 2024 Électronique Prévisions Financières Soins De Santé Résultats Du Deuxième Trimestre Merck KGaA
PRESS RELEASE published on 07/26/2024 at 18:50, 8 months 11 days ago EQS-Adhoc: Merck KGaA: Strong 2nd Quarter, Guidance raised Merck KGaA reports strong 2nd Quarter results, raises guidance for fiscal 2024, projecting higher net sales, EBITDA, and EPS. Healthcare and Electronics drive performance Healthcare Guidance Merck KGaA Electronics 2nd Quarter
BRIEF published on 06/24/2024 at 19:05, 9 months 12 days ago Merck KGaA Discontinues Phase III Trials of Xevinapant in Head & Neck Cancer Clinical Trials Head And Neck Cancer Merck KGaA Phase III Trials Xevinapant
BRIEF published on 06/24/2024 at 19:05, 9 months 12 days ago Merck KGaA interrompt les essais de phase III du Xevinapant dans le traitement du cancer de la tête et du cou Essais Cliniques Cancer De La Tête Et Du Cou Merck KGaA Xevinapant Essais De Phase III
PRESS RELEASE published on 06/24/2024 at 19:00, 9 months 12 days ago EQS-Adhoc: Merck KGaA: Phase III trials of xevinapant in locally advanced head & neck cancer discontinued Merck KGaA discontinues phase III trials of xevinapant in locally advanced head & neck cancer after interim analysis results. Xevinapant is currently under clinical investigation Merck KGaA Phase III Trials Xevinapant Locally Advanced Head & Neck Cancer Clinical Investigation
PRESS RELEASE published on 10/11/2023 at 22:06, 1 year 5 months ago EMD Electronics Celebrates Opening of New Arizona Factory, Contributing to the State's Growing Semiconductor Industry
Published on 04/07/2025 at 00:05, 6 hours 45 minutes ago Sea Pharmaceuticals Announces Strategic Relationship to Advance Treatments For Patients with CNS Disorders
Published on 04/05/2025 at 01:50, 2 days 5 hours ago Battery X Metals Achieves Graphite Recovery Breakthrough in Partnership with Global Top 20 University in Controlled Trials
Published on 04/06/2025 at 18:20, 12 hours 29 minutes ago EQS-Adhoc: QIAGEN N.V.: QIAGEN announces strong preliminary Q1 2025 results and updates full-year 2025 adjusted earnings per share outlook
Published on 04/06/2025 at 15:09, 15 hours 41 minutes ago EQS-Adhoc: DEUTZ acquires developer of electrification solutions UMS
Published on 04/04/2025 at 19:00, 2 days 11 hours ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 04/04/2025 at 18:51, 2 days 11 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/04/2025 at 18:30, 2 days 12 hours ago Forbo shareholders approved all proposals of the Board of Directors
Published on 04/04/2025 at 19:18, 2 days 11 hours ago Mersen: Number of shares and voting rights as of March 31, 2025
Published on 04/04/2025 at 19:18, 2 days 11 hours ago Mersen : nombre d'actions et de droits de vote au 31 mars 2025
Published on 04/04/2025 at 18:17, 2 days 12 hours ago Reporting on share buyback transactions carried out between March 31 and April 3, 2025
Published on 04/04/2025 at 18:17, 2 days 12 hours ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 31 mars et le 3 avril 2025
Published on 04/04/2025 at 18:13, 2 days 12 hours ago Total number of voting rights and shares making up the share capital at March 31, 2025
